nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0414	0.0414	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—PRKACA—adrenal gland cancer	0.0398	0.0398	CbGpPWpGaD
Decamethonium—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0389	0.0389	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—CDC42—adrenal gland cancer	0.0338	0.0338	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0311	0.0311	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0292	0.0292	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—KCNJ5—adrenal gland cancer	0.0238	0.0238	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—BAD—adrenal gland cancer	0.0236	0.0236	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.023	0.023	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—KCNJ5—adrenal gland cancer	0.0224	0.0224	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—PRKACA—adrenal gland cancer	0.02	0.02	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0196	0.0196	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0186	0.0186	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0173	0.0173	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—CDC42—adrenal gland cancer	0.017	0.017	CbGpPWpGaD
Decamethonium—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0158	0.0158	CbGpPWpGaD
Decamethonium—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0149	0.0149	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0147	0.0147	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.014	0.014	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—KCNJ5—adrenal gland cancer	0.0132	0.0132	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0126	0.0126	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0119	0.0119	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—BAD—adrenal gland cancer	0.0119	0.0119	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—KCNJ5—adrenal gland cancer	0.0113	0.0113	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0112	0.0112	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.011	0.011	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—REN—adrenal gland cancer	0.0108	0.0108	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0107	0.0107	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00961	0.00961	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—REN—adrenal gland cancer	0.0096	0.0096	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—PRKACA—adrenal gland cancer	0.00913	0.00913	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00882	0.00882	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00864	0.00864	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—PRKACA—adrenal gland cancer	0.00858	0.00858	CbGpPWpGaD
Decamethonium—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00854	0.00854	CbGpPWpGaD
Decamethonium—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00803	0.00803	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00771	0.00771	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00756	0.00756	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0075	0.0075	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00743	0.00743	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00712	0.00712	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00679	0.00679	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00674	0.00674	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00663	0.00663	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—KCNJ5—adrenal gland cancer	0.00662	0.00662	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00642	0.00642	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00632	0.00632	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00604	0.00604	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—KCNJ5—adrenal gland cancer	0.00591	0.00591	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00576	0.00576	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00563	0.00563	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00543	0.00543	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00535	0.00535	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00513	0.00513	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—PRKACA—adrenal gland cancer	0.00508	0.00508	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00493	0.00493	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00493	0.00493	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—BRAF—adrenal gland cancer	0.00492	0.00492	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00475	0.00475	CbGpPWpGaD
Decamethonium—ACHE—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.00466	0.00466	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—BRAF—adrenal gland cancer	0.00462	0.00462	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—PRKACA—adrenal gland cancer	0.00432	0.00432	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0041	0.0041	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—PRKACA—adrenal gland cancer	0.0041	0.0041	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00404	0.00404	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.0039	0.0039	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00384	0.00384	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—POMC—adrenal gland cancer	0.00358	0.00358	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00357	0.00357	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00332	0.00332	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00331	0.00331	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00325	0.00325	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—POMC—adrenal gland cancer	0.0032	0.0032	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00312	0.00312	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00304	0.00304	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00298	0.00298	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00295	0.00295	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00295	0.00295	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00291	0.00291	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0029	0.0029	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00288	0.00288	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00285	0.00285	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00274	0.00274	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—BRAF—adrenal gland cancer	0.00274	0.00274	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00271	0.00271	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00264	0.00264	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00263	0.00263	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.00256	0.00256	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00255	0.00255	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—PRKACA—adrenal gland cancer	0.00254	0.00254	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00246	0.00246	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00241	0.00241	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—BRAF—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00231	0.00231	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.00228	0.00228	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—PRKACA—adrenal gland cancer	0.00226	0.00226	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—BRAF—adrenal gland cancer	0.00221	0.00221	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—REN—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—POMC—adrenal gland cancer	0.00201	0.00201	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00187	0.00187	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SDHB—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—REN—adrenal gland cancer	0.00181	0.00181	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00169	0.00169	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00167	0.00167	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SDHB—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CDC42—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SPRY2—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00159	0.00159	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TSHR—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MEN1—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—BRAF—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00134	0.00134	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—BRAF—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—RRM1—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SDHD—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—POMC—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—RRM1—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SDHD—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—POMC—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—IGF2—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00097	0.00097	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00096	0.00096	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000947	0.000947	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDC42—adrenal gland cancer	0.000947	0.000947	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000943	0.000943	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IGF2—adrenal gland cancer	0.000913	0.000913	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GNAS—adrenal gland cancer	0.000905	0.000905	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—IGF2—adrenal gland cancer	0.000904	0.000904	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00089	0.00089	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000883	0.000883	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00088	0.00088	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000878	0.000878	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MED12—adrenal gland cancer	0.000876	0.000876	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000858	0.000858	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000856	0.000856	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000828	0.000828	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000783	0.000783	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MED12—adrenal gland cancer	0.000781	0.000781	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TERT—adrenal gland cancer	0.00076	0.00076	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000698	0.000698	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—POMC—adrenal gland cancer	0.000676	0.000676	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—BAD—adrenal gland cancer	0.000661	0.000661	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.000653	0.000653	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PRKACA—adrenal gland cancer	0.000639	0.000639	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000624	0.000624	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000614	0.000614	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—POMC—adrenal gland cancer	0.000609	0.000609	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—POMC—adrenal gland cancer	0.000603	0.000603	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—BRAF—adrenal gland cancer	0.000602	0.000602	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000583	0.000583	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000574	0.000574	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PRKACA—adrenal gland cancer	0.00057	0.00057	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000567	0.000567	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000557	0.000557	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000548	0.000548	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000521	0.000521	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000519	0.000519	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GNAS—adrenal gland cancer	0.000518	0.000518	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ABCB1—adrenal gland cancer	0.000508	0.000508	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000506	0.000506	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000498	0.000498	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000483	0.000483	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000475	0.000475	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GNAS—adrenal gland cancer	0.000462	0.000462	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ABCB1—adrenal gland cancer	0.000453	0.000453	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000435	0.000435	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000431	0.000431	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000369	0.000369	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000363	0.000363	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—POMC—adrenal gland cancer	0.000349	0.000349	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EGFR—adrenal gland cancer	0.000344	0.000344	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000335	0.000335	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—POMC—adrenal gland cancer	0.000311	0.000311	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000308	0.000308	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000297	0.000297	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000294	0.000294	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TP53—adrenal gland cancer	0.000289	0.000289	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000287	0.000287	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTGS2—adrenal gland cancer	0.000278	0.000278	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTGS2—adrenal gland cancer	0.000248	0.000248	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000247	0.000247	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000215	0.000215	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000198	0.000198	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000196	0.000196	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.00019	0.00019	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000141	0.000141	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000112	0.000112	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	9.4e-05	9.4e-05	CbGpPWpGaD
